W. Eric Bowditch
President, INTAPRO
W. Eric Bowditch is a senior
international pharmaceutical executive with over 30 years
experience in global business development, licensing, marketing
and strategic planning. Eric serves as President, INTAPRO LLC, a
company focused on business development, licensing and
partnering.
Prior to founding INTAPRO, Eric
was President & CEO, Strakan Life Sciences, Inc. between 1998
and 2002. Between 1996 and 1998, he was Vice President, Business
Development and Corporate Officer with Access Pharmaceuticals,
Inc. From 1992 to 1996, he was Head of Worldwide Business
Development, Ohmeda Pharmaceuticals before the acquisition by
Baxter International. From 1984-1991, he was Worldwide Director,
Business Development and Strategic Marketing, Rhone-Poulenc
Rorer (now Sanofi-Aventis). Prior to Rhone-Poulenc Rorer, Eric
held a number of marketing positions in the UK at E. R. Squibb
(now BMS) and Boehringer Ingelheim.
Eric holds a degree in business
administration from University of London and a postgraduate
diploma in management studies and marketing.
|
|
W. Eric Bowditch
President, INTAPRO
|
